NCT07124546

Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers

Development of Acceptance and Commitment Therapy for Cancer Distress Among Rural and Urban Patients With Hepatobiliary Cancers (ACT-HBC)

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This clinical trial studies whether Acceptance and Commitment Therapy for patients with hepatobiliary cancers (ACT-HBC) can be used to help improve cancer distress. Patients with hepatobiliary cancer (HBC) often experience high levels of distress and reductions in quality of life. ACT-HBC is a behavioral intervention tailored to patients with HBC. It helps patients cope with difficult thoughts and emotions while staying connected to what matters most in life, which may be an effective way to improve cancer distress.

Conditions

• Malignant Hepatobiliary Neoplasm

Interventions

Type	Name	Description
BEHAVIORAL	Acceptance and Commitment Therapy	Attend ACT-HBC telehealth group sessions
OTHER	Questionnaire Administration	Ancillary studies
OTHER	Telemedicine	Attend ACT-HBC telehealth group sessions

Timeline

• Start date: 2025-05-28
• Primary completion: 2027-05-30
• Completion: 2027-05-30
• First posted: 2025-08-15
• Last updated: 2025-08-15

Locations

1 site across 1 country: United States